Browse the corpus

Central pain syndrome (CPS) refers to chronic pain arising from injury or dysfunction within the central nervous system (CNS). Risk factors include genetic predisposition and environmental exposures such as trauma, stroke, or neuroinflammatory disease. The underlying mechanism involves central sensitization, in which the CNS amplifies pain signals despite minimal or absent peripheral input. Individuals with CPS may report burning, tingling, or stabbing pain, along with heightened responses to nonpainful stimuli (allodynia) and painful stimuli (hyperalgesia). Diagnosis of CPS is clinical and typically requires exclusion of peripheral or structural causes of pain. Management is multimodal and may include pharmacological therapy (eg, antidepressants and anticonvulsants), physical rehabilitation, and psychological support. Prognosis varies; many individuals experience persistent, functionally limiting symptoms that adversely affect quality of life. This activity focuses on the evaluation and management of CPS, including a review of relevant neuroanatomy, risk factors, etiology, pathophysiology, and clinical presentation. This activity also presents current diagnostic and therapeutic recommendations to guide evidence-based practice. Additionally, this activity fosters effective collaboration within an interprofessional healthcare team, optimizing care for individuals with CPS and enhancing clinical outcomes. Objectives: Identify key clinical features and mechanisms of central pain syndrome, including central sensitization. Implement evidence-based, multimodal management strategies, including both pharmacological and non-pharmacological therapies. Apply current diagnostic criteria and decision-making frameworks to avoid delays in recognition. Collaborate with the interprofessional healthcare team to educate, treat, and monitor patients with central pain syndrome to improve health outcomes. Access free multiple choice questions on this topic.

Central sensitization occurs when the nervous system remains in a state of hyperactivity, resulting in increased neuronal excitability and enhanced synaptic transmission.[1][2] Despite limited input from the peripheral nervous system (PNS), the central nervous system (CNS) persistently amplifies pain signals. This hyperexcitability heightens pain sensitivity through mechanisms such as ion channel upregulation, reduced inhibitory control, and maladaptive neural plasticity.[3] This state, which includes "wind-up" (temporal summation) as an acute precursor, causes ordinary touch to produce pain (allodynia) or a mild stimulus to feel more painful (hyperalgesia).[4] Central pain syndrome (CPS), a subset of centralized pain disorders, results from CNS conditions such as stroke or spinal cord injury. CPS involves pathophysiological mechanisms distinct from those underlying nociplastic pain conditions, such as fibromyalgia. Although less prevalent than nociplastic pain, CPS frequently develops following neurological injury, making it crucial for healthcare providers to differentiate it from other centralized pain syndromes to guide appropriate interventions. Exposure to cold or emotional stress may exacerbate symptoms, but it is not essential for diagnosis. CPS frequently coexists with memory impairment and anxiety, reflecting shared neurobiological pathways. Treatment involves targeted CNS therapies, including antidepressants such as serotonin-norepinephrine reuptake inhibitors (SNRIs) and anticonvulsants such as gabapentin. Conventional pain relievers, including nonsteroidal anti-inflammatory drugs (NSAIDs) and opioids, are typically ineffective for centrally mediated pain. Chronic pain affects up to 1 in 5 adults, with a substantial proportion exhibiting features of centralized pain symptoms.[5]

Historically, CPS was regarded as a psychiatric diagnosis following traumatic brain injury or as a diagnosis of exclusion. Early theories proposed that CPS reflected a dysfunction of the nervous system, in contrast to the adaptive mechanisms underlying musculoskeletal (nociceptive) pain.[6] For example, withdrawing one's hand from an open flame is beneficial, as pain serves as a protective mechanism to limit harm. In contrast, CPS represents pain that lacks protective value—indeed, it is maladaptive. Sensory amplification and pain intensify as multiple systemic syndromes overlap. An estimated 2% to 4% of the population experience fibromyalgia, 1% have chronic fatigue, and 4% are affected by somatoform disorders. Moreover, significant overlap exists between regional pain syndromes and psychiatric disorders. CPS is a type of neuropathic pain that originates within the CNS. The condition can occur in patients with a history of multiple sclerosis or a recent stroke. Acute pain that becomes chronic may undergo centralization, putting patients at risk of developing centralized pain. Although patients with CPS often perceive their pain as originating peripherally, it is predominantly centralized. Neural signals are amplified, leading to hyperalgesia and allodynia. Centralization of pain can occur when peripheral nociceptive input, such as that from rheumatoid arthritis, persists over time, creating a mixed pain state. Chronic back pain provides a common example of peripheral pain that centralizes over time.[7][8] Risk factors for fibromyalgia mirror those for CPS and include trauma, infection, chronic stress, obesity, and depression. Centralized sensitization occurs with minimal or no nociceptive input. Functional neuroimaging can aid in diagnosing CPS.

Although patients with CPS often perceive their pain as originating peripherally, it is predominantly centralized. Neural signals are amplified, leading to hyperalgesia and allodynia. Centralization of pain can occur when peripheral nociceptive input, such as that from rheumatoid arthritis, persists over time, creating a mixed pain state. Chronic back pain provides a common example of peripheral pain that centralizes over time.[7][8] Risk factors for fibromyalgia mirror those for CPS and include trauma, infection, chronic stress, obesity, and depression. Centralized sensitization occurs with minimal or no nociceptive input. Functional neuroimaging can aid in diagnosing CPS. In reality, centralized pain is not mutually exclusive from other types of pain. An overlap exists between pain states. Any central pain state may include a component of peripheral pain, such as peripheral neuropathy. Additionally, a significant family predisposition to CPS exists.[9][10] Psychological stressors can also trigger worsening symptoms. In many cases, environmental factors cause a triggering event in patients with genetic susceptibility, leading to the development of widespread, centralized pain.[11][12] Therefore, managing environmental stressors is crucial. Early-life trauma, infection, or emotional stress contributes to the development of centralized pain in approximately 5% to 10% of patients.[13][14] Centralized pain is influenced approximately equally by environmental and genetic factors, each contributing around 50% to its development. First-degree relatives have an 8-fold higher risk of developing centralized pain compared with the general population. However, no significant difference exists based on the sex of the patient or family member. The genetic association is more prominent in families with a history of mood disorders.[15][16] Although a genetic component for centralized pain may exist, no single causative genetic polymorphism has been identified.[17]

Chronic widespread pain, associated with centralized pain, occurs in 10% to 40% of patients with rheumatoid arthritis, psoriatic arthritis, osteoarthritis, spondyloarthritis, and systemic lupus erythematosus (SLE). Centralized pain occurs in 5% to 15% of the general population, most commonly in individuals with fibromyalgia. Diagnostic criteria for fibromyalgia substantially overlap with those for centralized pain, and patients reporting severe fatigue have a fivefold higher risk of developing widespread pain.[18] The prevalence of centralized pain in patients with knee osteoarthritis ranges from 10% to 15%, with higher rates observed in those with bilateral compared to unilateral knee pain.[19][20][21] The reported centralized pain in patients with rheumatoid arthritis is estimated to be 13% to 40%. A key concern in this patient population is the risk of overtreating rheumatoid arthritis due to symptom amplification driven by centralized pain. Patients with comorbid fibromyalgia and rheumatoid arthritis typically have lower inflammatory markers but report a poorer quality of life compared with those who have rheumatoid arthritis alone.[22][23] Centralized pain occurs in 10% to 30% of patients with spondyloarthritis. Among those with ankylosing spondylitis, 13% to 20% meet the criteria for fibromyalgia.[24][25][26] Patients with widespread pain are more likely to experience clinically significant fatigue and comorbid mood disorders, often with moderate-to-severe symptoms. In a study, centralized pain was identified in 53% of patients with psoriatic arthritis, compared with only 5% in the average population.[27] Patients with centralized pain were also more likely to be lost to follow-up after initiating treatment. Additionally, centralized pain affects 20% to 40% of patients with SLE or Sjögren syndrome, with prevalence increasing as chronic disease progresses and in those with comorbid depression.[28][29] More than one-third of women with chronic back pain experience centralized pain. The daily impact of centralized pain is significant in patients with chronic back pain, often causing severe limitations in activity. Given the high prevalence of widespread, centralized pain in women with chronic low back pain, CPS should be considered in the differential diagnosis for this patient population.[30]

The pathogenesis of CPS remains unclear. The underlying mechanism may resemble those of neuropathic pain arising from other body regions or may involve overlapping lesions, features, and associated conditions.[31] Both central and peripheral mechanisms contribute to neuropathic pain, including alterations in the brain, spinal cord, and descending modulatory pathways.[32] Commonly affected regions include the lateral medulla, pontine base, and lateral or posterior thalamus.[33]

The diagnosis of CPS requires symptoms persisting for a minimum of 3 months, characterized by widespread allodynia or hyperalgesia in the absence of an identifiable nociceptive source. The International Association for the Study of Pain (IASP) defines CPS as pain resulting from a CNS lesion or disease. Central sensitization—characterized by heightened responsiveness of nociceptive neurons in the CNS to normal or subthreshold input—is a key mechanism underlying the condition. CPS may present as generalized pain or as pain affecting multiple discrete anatomical regions. Reproducible pain elicited by normal pressure during palpation typically indicates hyperalgesia or allodynia secondary to mechanical stimulation of joints or muscles. Clinical features frequently associated with CPS include mood disturbances, fatigue, cognitive impairment, disordered sleep, pain catastrophizing, and symptoms suggestive of neuropathic pain, such as burning, numbness, tingling, and paresthesias. Affected individuals often report multifocal pain and memory difficulties and may meet diagnostic criteria for major depressive or generalized anxiety disorder. Noxious stimuli, such as extreme temperatures or loud auditory input, may exacerbate symptom intensity.[35] Using a standardized body diagram may assist in documenting pain distribution. A comprehensive pain history should include the onset, description, location, radiation, quality, and severity of the pain. Additional elements include the mechanism of injury (if applicable), aggravating and relieving factors, frequency of symptoms, and presence of breakthrough pain. Associated features should also be assessed, such as muscle spasms or aches, temperature changes, restricted range of motion, morning stiffness, weakness, muscle strength, sensory changes, and alterations in hair, skin, or nail integrity. Physical examination should include a detailed neurological assessment and a focused examination of the painful area. When evaluating for CPS, a complete musculoskeletal examination is recommended. Assessment for symmetrical tender points, characteristic of fibromyalgia, may also provide additional diagnostic insight. Any tenderness over soft tissues or joints should be documented.

Physical examination should include a detailed neurological assessment and a focused examination of the painful area. When evaluating for CPS, a complete musculoskeletal examination is recommended. Assessment for symmetrical tender points, characteristic of fibromyalgia, may also provide additional diagnostic insight. Any tenderness over soft tissues or joints should be documented. To support a diagnosis of CPS, pain often appears in a widespread distribution, affecting the axial skeleton, both sides of the body, and regions above and below the diaphragm. Conversely, CPS becomes less likely when findings include swelling, structural abnormalities, focal neurological deficits, or signs of joint inflammation.

The diagnosis of CPS remains primarily clinical, as the results of standard laboratory tests, including complete blood count, erythrocyte sedimentation rate, C-reactive protein, thyroid-stimulating hormone, and creatine kinase, are typically unremarkable.[36] Laboratory testing should be reserved for cases when clinical suspicion warrants further evaluation. Genetic biomarkers for CPS are currently limited, and rheumatologic markers such as rheumatoid factor and antinuclear antibody are not indicated unless an autoimmune process is suspected. Screening tools for CPS include the Central Sensitization Inventory (CSI) and painDETECT. These modalities assist in evaluating neuropathic pain and centralized pain syndromes such as fibromyalgia, respectively.[37] However, distinguishing between central and peripheral origins of pain can be challenging; for instance, painDETECT cannot localize the source of pain to either the CNS or the PNS with precision.[38] Neuroimaging modalities, including magnetic resonance imaging (MRI) and functional MRI (fMRI), may aid in diagnosing CPS. FMRI studies have demonstrated structural and functional brain alterations in patients with chronic pain conditions. For instance, individuals with fibromyalgia often demonstrate distinct patterns of brain activation. FMRI may help identify patients at risk for developing centralized pain disorders and contribute to diagnosis and prognosis.[39] Notable fMRI findings include reduced brain volume, decreased cortical thickness, and elevated levels of excitatory neurotransmitters.[40] Furthermore, fMRI provides insight into connectivity among multiple brain regions, with the degree of alteration often correlating with the extent of a patient's pain. In fibromyalgia, fMRI may offer an objective measure of symptom severity.[41] Patients with fibromyalgia demonstrate pain-related brain activity patterns that differ from those in the general population. As a diagnostic tool, fMRI shows promise for future application in evaluating various chronic pain disorders.[42] Positron emission tomography (PET) and electroencephalography (EEG) have also revealed heightened pain responses in individuals with CPS.[43][44]

Management of CPS often focuses on addressing the underlying chronic disease associated with centralized pain. Controlling comorbid conditions can significantly reduce pain severity.[45] For instance, in knee osteoarthritis, neuroimaging abnormalities related to centralized pain have been shown to improve following joint replacement. Central pain disorders generally respond better to neuromodulators, antiepileptics, or antidepressants than to pharmacologic agents targeting peripheral pain, such as NSAIDs or opioids. Nonpharmacological strategies, particularly cognitive-behavioral therapy, form the foundation of CPS management. A comprehensive, individualized approach is essential, as the underlying pathology may involve structural, immunological, or inflammatory mechanisms. Strong evidence supports the use of neuromodulation techniques in the management of chronic pain. These methods include deep brain stimulation (DBS), motor cortex stimulation (MCS), and peripheral nerve stimulation, as well as noninvasive modalities such as repetitive transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), and transcutaneous electrical nerve stimulation (TENS).[46] Self-directed or therapist-directed physical therapy techniques can include traction, massage, ultrasonographic therapy, hot or cold applications, positioning, meditation, active visualization, prayer, stretching exercises, and TENS. Female patients with chronic pelvic pain syndrome may benefit from myofascial physical therapy, which can alleviate hypertonicity, improve endogenous inhibitory system function, reduce sensitivity to experimental pain, and provide psychological benefits.[47] TENS is commonly used to treat rheumatoid arthritis and osteoarthritis. Electrodes are placed over or near the pain site, with the dipole positioned parallel to major nerve trunks. However, TENS can cause hypersensitivity as an adverse effect and should be avoided in pregnant individuals, those with demand-type pacemakers, or when applied near the carotid sinus. MCS and DBS are effective treatment options for patients with refractory pain, central pain, and peripheral neuropathy.[48] Occupational therapy proves beneficial for patients with chronic pain, particularly those with regional chronic pain syndrome, by promoting physical activity and helping manage physical symptoms.

TENS is commonly used to treat rheumatoid arthritis and osteoarthritis. Electrodes are placed over or near the pain site, with the dipole positioned parallel to major nerve trunks. However, TENS can cause hypersensitivity as an adverse effect and should be avoided in pregnant individuals, those with demand-type pacemakers, or when applied near the carotid sinus. MCS and DBS are effective treatment options for patients with refractory pain, central pain, and peripheral neuropathy.[48] Occupational therapy proves beneficial for patients with chronic pain, particularly those with regional chronic pain syndrome, by promoting physical activity and helping manage physical symptoms. Pharmacological treatments for CPS include tricyclic antidepressants, SNRIs, and anticonvulsants. Strong evidence supports the use of tricyclic antidepressants such as amitriptyline, SNRIs such as duloxetine and venlafaxine, and anticonvulsants such as pregabalin and gabapentin. Moderate evidence exists for tramadol and selective serotonin reuptake inhibitors, whereas weak evidence supports the use of S-adenosyl-L-methionine.

Central sensitization manifests in various chronic pain disorders, including fibromyalgia, interstitial cystitis, temporomandibular joint disease, and irritable bowel syndrome. The differential diagnosis for CPS is broad, encompassing autoimmune disorders such as rheumatoid arthritis and polymyalgia rheumatica, myopathies, painful peripheral neuropathies, somatization disorder, malingering, and withdrawal phenomena from physiological or psychological dependence on habit-forming substances. Central sensitization frequently accompanies chronic back and neck pain and is also associated with conditions such as trauma, carpal tunnel syndrome, complex regional pain syndrome, lateral epicondylitis, osteoarthritis, and joint hypermobility syndrome. CPS develops following a stroke or as a sequela of neurological disorders such as multiple sclerosis.[49][50] Thalamic stroke, in particular, is linked to a specific form of CPS. Mood disorders, including major depressive disorder and generalized anxiety disorder, are also commonly comorbid with CPS.

A medical oncology consultation is warranted when malignancy is suspected, acute inflammatory markers are elevated without an identifiable cause, treatment of primary or metastatic lesions is indicated, or external beam radiation is being considered. Pain management in cancer survivors and patients undergoing cancer therapies involves special considerations, and referral to a physician authorized to recommend medical cannabis may be appropriate.[55] In the United States, relevant guidelines vary by state.

Prognosis improves when the underlying cause of pain can be cured, corrected, or effectively managed —for example, through shoulder replacement in patients with osteoarthritis. Individuals with osteoarthritis and centralized sensitization may experience pain relief with pharmacologic therapy targeting osteoarthritis; however, they often report poorer pain outcomes following joint replacement surgery.[56] In patients with osteoarthritis comorbid with CPS, pain severity does not correlate with the radiographic severity of osteoarthritis. Additionally, patients with radiological evidence of osteoarthritis in a single joint are at increased risk of developing pain in multiple joints. This comorbid population also exhibits more synovitis and effusion in knee osteoarthritis. Central sensitization contributes to inflammatory arthritis and affects a significant subset of the patient population. For example, individuals with rheumatoid arthritis and comorbid fibromyalgia report worse pain, poorer mental health, and greater reliance on pain medications, including prednisone, despite having lower levels of inflammatory markers.[57][58] Patients with inflammatory arthritis and centralized sensitization experience poorer overall outcomes.[59] Additionally, these patients also experience hyperalgesia at both articular and nonarticular sites.[60]

The impact of central sensitization extends across various conditions. In rheumatoid arthritis, central pain is associated with neuropathic symptoms, higher pain scores without changes in inflammatory markers, increased adverse outcomes, and reduced remission rates. Central sensitization also contributes to the increased use of opioids and higher pain severity in patients with osteoarthritis, leading to poorer patient outcomes. Patients with bilateral knee pain are more likely to experience pain in additional joints within a year. In spondyloarthritis, central sensitization is associated with worse clinical outcomes, higher disease scores, and poorer treatment responses. In SLE, centralized pain is associated with greater sleep disturbances, mood changes, and worse overall outcomes. Patients with chronic back pain and central sensitization experience more intense pain and mood disturbances, as well as an increase in adverse outcomes. Joint hypermobility syndrome is linked to greater pain severity and poorer patient outcomes. In carpal tunnel syndrome, central sensitization is associated with poorer surgical outcomes, while in lateral epicondylitis, it correlates with more severe pain, longer duration of pain, and a higher risk of failed treatments. For chronic whiplash injuries, centralized pain is associated with cognitive disturbances, more severe pain, and worse outcomes. Preoperative increases in fibromyalgia pain scores are associated with the use of more postoperative morphine equivalents and a reduced response to NSAIDs.[61]

The clinical scenario should guide specialist consultations. Rheumatology should be consulted for cases involving potential autoimmune disorders or elevated acute inflammatory markers. A neurology consultation is necessary when concerns arise for cerebrovascular accidents or other intracranial pathologies, such as demyelinating plaques. Physical medicine and rehabilitation can assist with electrodiagnostic evaluations to differentiate between inflammatory and noninflammatory myopathies and to identify peripheral neuropathy, especially if conditions such as acute or chronic inflammatory demyelinating polyneuropathy are considered in the differential diagnosis. Neurosurgery or orthopedic surgery should be involved if concerns arise about structurally relevant and potentially correctable spinal or peripheral joint pathologies. Neurosurgical intervention may also be indicated in certain cases for temporal lobe stimulation. Psychiatry or psychology is important for addressing potential somatization or hypochondriasis, as well as providing emotional support in the management of chronic, intractable pain. Pain management consultations are essential for exploring both interventional and noninterventional treatment options, including medication management and the consideration of implantable technologies, such as subarachnoid pain pumps. Vascular surgery or interventional radiology should be consulted if a vascular etiology is suspected.

CPS arises from heightened sensitivity within the CNS, which lowers the threshold for pain perception. Educating patients and clinicians about the pathophysiology, prevalence, and management of this condition is essential for effective prevention and treatment, particularly in individuals with chronic diseases. CPS manifests when the CNS becomes hyperresponsive, resulting in conditions such as allodynia, which is pain elicited by normally nonpainful stimuli—and hyperalgesia—exaggerated responses to painful stimuli. Up to 20% of individuals with chronic pain from any cause may exhibit features of CPS, highlighting its clinical importance. The risk increases in patients with rheumatologic or musculoskeletal conditions lasting longer than three months, with both environmental and genetic factors contributing to their development. Importantly, CPS can coexist with peripheral pain, further complicating diagnosis and management. Over time, chronic disease itself may amplify central sensitization, increasing the prevalence of dual pain syndromes. fMRI has emerged as a valuable tool for identifying centralized pain patterns, thereby enhancing diagnostic accuracy and clinical precision. CPS affects numerous chronic disease states, and is particularly associated with worse outcomes in osteoarthritis and rheumatoid arthritis. Managing both the primary condition and CPS simultaneously can lead to improved symptom control. Effective management often requires collaboration between a primary care physician (PCP) and a specialist in pain medicine. First-line pharmacological interventions include antidepressants and anticonvulsants, which help modulate abnormal CNS pain processing. Early recognition and management of centralized pain in the course of chronic illness may help prevent progression to more debilitating states. A comprehensive, dual-focused treatment approach offers the best opportunity to enhance the quality of life for patients with CPS.

Clinicians should remember that pain is a symptom, not an etiology or a diagnosis. Every symptom reflects an underlying process, whether identified, treatable, or yet to be recognized in the current scientific literature. Approximately 20% of individuals with chronic pain from known causes also experience CPS or widespread pain in other regions. Effective treatment requires addressing the primary cause of pain, acknowledging the limitations in treating certain conditions, and the distressing symptoms themselves, including pain.

Effective management of CPS requires a coordinated, interprofessional approach involving PCPs, pain medicine specialists, pharmacists, nurses, and subspecialists such as rheumatologists or neurologists. Early recognition of centralized pain is critical, as its treatment differs from that of peripheral or mechanical pain. Without appropriate diagnosis and management, CPS is associated with significant morbidity. Initial evaluation typically includes laboratory tests such as complete blood count, erythrocyte sedimentation rate, C-reactive protein, creatine phosphokinase, and aldolase to help exclude underlying inflammatory or myopathic conditions. Clinicians should assess for hallmark features of central pain, including allodynia and hyperalgesia, particularly in patients with pain that persists for longer than 3 months. Both genetic and environmental factors may contribute to the development and persistence of CPS. Pharmacological management often involves consultation with a pharmacist to guide the use of antidepressants, anticonvulsants, and other agents, including over-the-counter supplements or experimental therapies such as methylene blue. Pain medicine specialists may consider neuromodulation for refractory cases. When available, fMRI may provide supportive diagnostic information and should be discussed with a radiologist. Subspecialist input from rheumatology or neurology is often necessary to address underlying autoimmune or neurologic contributors to pain. Management of CPS requires collaboration across multiple healthcare disciplines. However, coordination challenges frequently arise, as overlapping treatments, redundant testing, and polypharmacy increase the risk of harm. To ensure consistency and safety, a single lead clinician, often referred to as the “quarterback,” should oversee the overall care plan and track each clinical decision. This role is commonly filled by neurologists or physicians in physical medicine and rehabilitation who hold additional board certification in pain management. Nonetheless, a PCP can also serve in this capacity if they have the interest and expertise. However, many PCPs feel underprepared or lack the time to manage such complex cases comprehensively.

Management of CPS requires collaboration across multiple healthcare disciplines. However, coordination challenges frequently arise, as overlapping treatments, redundant testing, and polypharmacy increase the risk of harm. To ensure consistency and safety, a single lead clinician, often referred to as the “quarterback,” should oversee the overall care plan and track each clinical decision. This role is commonly filled by neurologists or physicians in physical medicine and rehabilitation who hold additional board certification in pain management. Nonetheless, a PCP can also serve in this capacity if they have the interest and expertise. However, many PCPs feel underprepared or lack the time to manage such complex cases comprehensively. Preventing the progression to centralized sensitization is a critical goal due to the high burden of morbidity associated with this condition. Once established, symptoms of CPS are often persistent and do not fully resolve, and long-term outcomes remain guarded despite comprehensive care. Nursing staff play a critical role in the care of individuals with centralized pain. These professionals act as liaisons among healthcare professionals, monitor patient progress, and often spend more time with patients than most other team members. This extended bedside presence increases the likelihood of detecting subtle physical or emotional changes that might otherwise go unrecognized. When consistently communicated with the healthcare team, nurses' observations can significantly influence management decisions. Additionally, nurses provide ongoing education and support, helping patients navigate their treatment plans and maintain realistic expectations. Physical and occupational therapists contribute by addressing functional limitations and working to reduce long-term disability. Their hands-on involvement often allows them to detect early changes in limb temperature, color, or range of motion, as well as shifts in mood, affect, or motivation. These observations should be promptly communicated to the managing physician. In addition, therapy assistants and specialized professionals, such as music, art, play, or shop therapists, may offer valuable insights and therapeutic benefits. Together, each of these healthcare team members plays a crucial role in helping patients adapt, cope, and achieve an improved quality of life.

Physical and occupational therapists contribute by addressing functional limitations and working to reduce long-term disability. Their hands-on involvement often allows them to detect early changes in limb temperature, color, or range of motion, as well as shifts in mood, affect, or motivation. These observations should be promptly communicated to the managing physician. In addition, therapy assistants and specialized professionals, such as music, art, play, or shop therapists, may offer valuable insights and therapeutic benefits. Together, each of these healthcare team members plays a crucial role in helping patients adapt, cope, and achieve an improved quality of life. Effective management of CPS relies on providing meaningful patient education, fostering patient-centered communication, and a commitment to making incremental progress. Although complete pain elimination may not be achievable, an interprofessional team approach can consistently enhance functional outcomes and overall well-being.